← SynDRA
(R)-3-Carboxy-4-hydroxyphenylglycine
SynDRA canonical compound SYN0878575 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | GRIN1 | GRIN2A | GRIN2B | GRIN2C |
| Mechanism of action | glutamate receptor antagonist |
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ATAD5
- ATM
- ATXN2
- CBX1
- GMNN
- IDH1
- KAT2A
- KDM4A
- L3MBTL1
- NFE2L2
- PTH1R
- SMPD1
- TDP1
- TLR9
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- COT2
- DRD3
- GEMI
- HCRTR1
- NCOA2
- NOD2
- RIPK2
Cross-references
Synonyms
- (R)-3C4HPG
- 5-[(R)-amino(carboxy)methyl]-2-hydroxybenzoic acid
- (R)-5-(Amino(carboxy)methyl)-2-hydroxybenzoic acid
- Tocris-0328
- NCGC00024538-01
- Biomol-NT_000227
- BPBio1_001346
- orb1704178
- SCHEMBL12648648
- SCHEMBL30725365
- BDBM82250
- HMS3411E11
- HMS3675E11
- 3-carboxy-4-hydroxyphenylglycine-(R)
- AKOS024457521
- NCGC00024538-02
- DA-69185
- MS-33248
- CAS_13861-03-5
- CB7394016
- HY-100842
- CS-0020489
- T23216
- SR-01000597639
- (R)-5-(Amino(carboxy)methyl)-2-hydroxybenzoicacid
- SR-01000597639-1
- BRD-K76592088-001-02-1
Look up (R)-3-Carboxy-4-hydroxyphenylglycine in the interactive SynDRA portal →